Marksans Pharma recalls 11,279 bottles of diabetes drug due to cancer causing chemical

​​The company has issued voluntary recall of one batch of Metformin extended release tablets (USP 500 mg) due to detection of NDMA (N-nitrosodimethylamine), Marksans Pharma said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3cMAmYW
via IFTTT